cgp 42112a has been researched along with angiotensinogen in 1 studies
Studies (cgp 42112a) | Trials (cgp 42112a) | Recent Studies (post-2010) (cgp 42112a) | Studies (angiotensinogen) | Trials (angiotensinogen) | Recent Studies (post-2010) (angiotensinogen) |
---|---|---|---|---|---|
233 | 0 | 35 | 3,606 | 78 | 875 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hayashi, M; Hirota, N; Ichihara, A; Kaneshiro, Y; Koura, Y; Okada, H; Saruta, T; Tada, Y; Tsuganezawa, H | 1 |
1 other study(ies) available for cgp 42112a and angiotensinogen
Article | Year |
---|---|
Angiotensin II type 2 receptor inhibits prorenin processing in juxtaglomerular cells.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Culture Media; Imidazoles; Immunohistochemistry; Juxtaglomerular Apparatus; Male; Oligopeptides; Pyridines; Rats; Rats, Sprague-Dawley; Renin; Tetrazoles | 2003 |